Drooid Logo
Back to story perspectives

Full Breakdown

Walmart Reports Slowest U.S. Same-Store Sales Growth in Six Years Amid Pharmacy Price Caps and Fuel-Cost Pressure

8/20/2026, 7:54:07 PM

Core Findings

  • U.S. comparable sales rose 2.6% in the quarter ended July 31, the smallest increase since 2020.
  • Adjusted earnings per share reached $0.81, beating the consensus estimate of $0.74, while revenue grew about 5.9% to roughly $187.9 billion.
  • The company lifted its full-year sales outlook to 4-5% growth and adjusted EPS to $2.80-$2.87, yet shares fell 6-9% after the release.

Background & Context

  • New federal negotiations on Medicare drug pricing introduced “maximum fair price” caps, lowering pharmacy margins and creating a 0.8-percentage-point drag on U.S. comparable sales.
  • Gasoline prices above $4 per gallon in July heightened household cost pressure, a factor the company cites for consumer trade-offs.
  • Walmart began receiving $2.9 billion in tariff refunds from a 2022 Supreme Court ruling; less than $100 million remains pending.

Data & Statistics

  • Revenue: $187.94 billion (FactSet consensus $186.62 billion).
  • U.S. comparable sales: 2.6% YoY; 3.4% when the health-and-wellness category is excluded.
  • E-commerce growth: 23-24% globally and in the United States.
  • Tariff-refund benefit: added 96 basis points to gross margin; incremental fuel-cost headwinds projected at $2 billion.
  • Net income: $6.37 billion; adjusted EPS $0.81.

Official Statements & Responses

  • CFO John David Rainey said the business remains strong and that the tariff refunds will be used to lower consumer prices, with the impact expected in the third quarter.
  • Rainey warned that higher fuel costs will add just over $2 billion of incremental expenses for the year.
  • CEO John Furner highlighted continued market-share gains among households earning over $100,000 and pointed to growth in e-commerce, advertising and Walmart+ membership as new profit engines.
  • The company noted that the pharmacy-price caps accounted for an 80-basis-point headwind to comparable sales.

Why It Matters

  • Walmart’s same-store sales metric is a widely watched barometer of U.S. consumer health; the slowdown signals that even value-oriented shoppers are feeling budget pressure.
  • Federal drug-price policy can directly suppress retail revenue, a factor analysts will monitor for future quarters.

Conflicting Reports & Gaps

  • Revenue figure: reported as $187.94 billion (AP, CNBC) and $187.9 billion (BigGo, CNBC TV18); the discrepancy reflects rounding differences.
  • Full-year guidance: most sources cite a 4-5% sales growth range, while earlier guidance was 3.5-4.5%; the exact upper bound varies between 4.5% and 5% across outlets.

Verbatim Quotes

  • “But consumers are still spending, and real wage growth is keeping pace, and so they've been very resilient in this environment,” — John David Rainey, CFO
  • “Customers tell us they’re still feeling some pressure,” — Walmart CEO John Furner

What’s Next

  • Walmart projects third-quarter net-sales growth of 3-3.75% (constant currency) and adjusted EPS of $0.62-$0.64, noting a >100-basis-point headwind from the timing shift of Flipkart’s “Big Billion Days” promotion.
  • The retailer will continue applying remaining tariff refunds to price reductions and expects the fuel-cost impact to remain around $2 billion for the fiscal year.